The majority of all parotid lymphomas are of the non-Hodgkin type and of B-cell origin. Primary natural killer cell lymphomas of the parotid gland are extremely rare. We present a case of natural killer cell lymphoma in a 34-year-old woman. The disease was refractory to chemotherapy, and the patient eventually succumbed due to lymphoma-associated hemophagocytic syndrome.
Masayuki Furukawa, MD, PhD
Department of Otorhinolarynology
Tohoku University School of Medicine
Seiryomachi Aoba-ku, Sendai 980-8574 (Japan)
Tel. +81 22 717 7304, Fax +81 22 717 7307, E-Mail firstname.lastname@example.org
Received: February 20, 2003
Accepted after revision: June 12, 2003
Number of Print Pages : 4
Number of Figures : 4, Number of Tables : 0, Number of References : 14
ORL (Journal for Oto-Rhino-Laryngology and Its Related Specialties)
Founded 1938 as ‘Practica Oto-Rhino-Laryngologica’ by J. Berberich and E. Schlittler, continued by L. Rüedi 1947–1970, E. Huizinga 1948–1970, C.R. Pfaltz 1968–1984
Vol. 65, No. 4, Year 2003 (Cover Date: July-August 2003)
Journal Editor: B.W. O’Malley, Baltimore, Md.
ISSN: 0301–1569 (print), 1423–0275 (Online)
For additional information: http://www.karger.com/orl
Article / Publication Details
Published online: 10/17/2003
Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0
ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)
For additional information: http://www.karger.com/ORL
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.